Search
for
Sort by
Research 91–120 of 472
- Transcutaneous implantation of valproic acid-encapsulated dissolving microneedles induces hair regrowth
- BCG'osis
- Neuroactive Steroids and Ethanol Exposure: Relevance to Ethanol Sensitivity and Alcohol Use Disorders Risk
- Medically significant monotypic species Martynia annua L.: A review on ethnobotany, phytochemistry and pharmacology
- Evaluation of Serum Levels of Nesfatin-1 and Insulin resistance in Patients with Acne Vulgaris
- Was the epidemic skin disease of 1891 due to acute arsenic poisoning?
- Balding man.
- Self-medication by Jockeys
- Lupus erythematosus: systemic and cutaneous manifestations
- Drug-Induced Skin, Nail and Hair Disorders
- Intestinal Dysbiosis and Biotin Deprivation Induce Alopecia through Overgrowth of Lactobacillus murinus in Mice
- Adverse Cutaneous Reactions to Antipsychotics
- Permanent Chemotherapy-Induced Alopecia in Patients with Breast Cancer: A 3-Year Prospective Cohort Study
- Oral Manifestations of Hematologic and Nutritional Diseases
- Exploring the Drug Repurposing Versatility of Valproic Acid as a Multifunctional Regulator of Innate and Adaptive Immune Cells
- Approach to the Management of Patients With Hidradenitis Suppurativa: A Consensus Document
- The Clinical Presentation of Systemic Lupus Erythematosus
- Trichotillomania and Trichophagia: Modern Diagnostic and Therapeutic Methods
- HAIR DISEASES
- Clinical management of cutaneous adverse events in patients on targeted anticancer therapies and immunotherapies: a national consensus statement by the Spanish Academy of Dermatology and Venereology and the Spanish Society of Medical Oncology
- Interventions for morphea
- Dermatological Manifestations of Stress in Normal and Psychiatric Populations
- Clinical Approach to the Patient With Alopecia
- Evaluation of hair loss
- Hair loss
- 25 years of ERβ: a personal journey
- Drug eruptions in dermatology
- Trends in Nanotechnology for Practical Applications
- Hair loss
- Evaluation of trichodynia (hair pain) during chemotherapy or tamoxifen treatment in breast cancer patients